← back to CIJ.World
CIJ.WorldArchive
download
  • Home
  • Sectors
    • Co-Social
    • Energy
    • Finance
    • Hospitality
    • Indicators
    • Jobs
    • Land
    • Logistics
    • Manufacturing
    • Mixed-use
    • Office
    • Other
    • Public Sector
    • Residential
    • Retail
  • Countries
    • Austria
    • Belgium
    • Bosnia and Herz.
    • Bulgaria
    • Croatia
    • Czech Republic
    • Estonia
    • France
    • Germany
    • Hungary
    • Italy
    • Kosovo
    • Luxembourg
    • Macedonia
    • Montenegro
    • Netherlands
    • Poland
    • Romania
    • Saudi Arabia
    • Slovakia
    • Spain
    • Sweden
    • United Kingdom
    • USA
  • CIJ TV
  • HOF Awards
  • CIJ Awards
  • Contact
CIJ.World > Manufacturing > Biovet opens factory in southern Bulgaria

Biovet opens factory in southern Bulgaria

18 September 2019

Biovet, a subsidiary of the drug maker Huvepharma, opened a new factory in Peshtera, southern Bulgaria, following a €150m investment. The project was supported by a €100m loan from the European Investment Bank. The factory will produce enzymes, probiotics and other pharmaceutical products. The company plans to hire 200 employees for the site. Biovet already operates three factories in Bulgaria in Botevgrad, Razgrad, Peshtera.

← previous article
next article →

Latest in this category

ग्रुप अर्बन होल्डिंग ने एक नई फैक्ट्री में बड़े पैमाने पर निवेश की घोषणा की Grup Åerban Holding oznamuje masivní investice do nové továrny Груп Аербан Холдинг најављује велика улагања у нову фабрику Grup Șerban Holding announces major EUR 62.5 million investment in new potato processing factory Grup Åerban Holding anuncia inversiones masivas en una nueva fábrica Czech manufacturing industry declines again in September, continuing downward trend Pesa teams up with Talgo to develop high-speed rail solutions for Poland The Dulcinella confectionery chain inaugurates the new factory in mid-2026
CIJ.World

Copyright © 2025 CIJ.World

Projekt i realizacja clivio.pl

Sections

News CIJ TV CIJ Awards Contact